Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Initial management with aflibercept, laser photocoagulation or observation in patients with diabetic eye disease?

Posted by on May 19, 2019 in Diabetes mellitus | 0 comments

In a nutshell This article investigated the rate of vision loss at 2 years among eyes with center involved-diabetic macular edema (CI-DME; vision loss in people with diabetes) initially managed with aflibercept (Eylea), laser photocoagulation (LP) or observation. The authors concluded that there was no significant difference in vision loss at 2...

Read More

Is sitagliptin added to insulin safe and effective in elderly patients with type 2 diabetes?

Posted by on May 19, 2019 in Diabetes mellitus | 0 comments

In a nutshell This article investigated the safety and effectiveness of sitagliptin (Januvia) in the management of type 2 diabetes (T2D) in elderly patients on insulin. The authors concluded that the addition of sitagliptin is effective and safe in all patients receiving it as add-on therapy to insulin.  Some background In type 2...

Read More

The effect of blood sugar awareness on weight retention after gestational diabetes

Posted by on May 18, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to see if women who were aware of their normal blood sugar levels after gestational diabetes (GDM) had more weight retention than those who were unaware of their blood sugar levels. The main finding of the study was that women who knew they had normal blood sugars after GDM had more weight retention than women who...

Read More

Ipragliflozin versus metformin for blood sugar control and fat reduction in type 2 diabetes

Posted by on May 17, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare the effectiveness of ipragliflozin compared to metformin in improving blood sugar control and reducing fat on organs in patients with type 2 diabetes (T2D) treated with sitagliptin. The main finding of the study was that ipragliflozin had greater reductions in fat but metformin had better blood sugar...

Read More

Weight management programme led by family doctors for reversing type 2 diabetes

Posted by on May 11, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to assess the remission of type 2 diabetes (T2D) during a family doctor-led weight management programme. The main finding of the study was that after 2 years of the programme more than one-third of patients had reversed their T2D. Some background The number of people with T2D is increasing. One factor is the...

Read More

High night-time blood sugar level associated with large baby in women with gestational diabetes

Posted by on Apr 28, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the role of glucose changes in the development of a large baby in women with gestational diabetes. The main finding of the study was that mothers who had large babies had high blood glucose levels at night. Some background Gestational diabetes mellitus (GDM) is diabetes that occurs during...

Read More

Dapagliflozin in type 1 diabetes

Posted by on Apr 27, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to assess continuous blood glucose levels in patients with type 1 diabetes (T1D) taking dapagliflozin as an add-on to insulin treatment. The main finding of the study was that patients treated with dapagliflozin had improved average blood glucose levels and less variation in blood glucose levels. Some background...

Read More